

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | COPI coating of Golgi vesicle (GO:0048205) | 5.87046880 |
| 2 | Golgi transport vesicle coating (GO:0048200) | 5.87046880 |
| 3 | establishment of integrated proviral latency (GO:0075713) | 5.23518918 |
| 4 | protein maturation by protein folding (GO:0022417) | 4.82210248 |
| 5 | CENP-A containing nucleosome assembly (GO:0034080) | 4.53574693 |
| 6 | chromatin remodeling at centromere (GO:0031055) | 4.53268731 |
| 7 | protein neddylation (GO:0045116) | 4.50551061 |
| 8 | mitotic G2 DNA damage checkpoint (GO:0007095) | 4.46312021 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 4.27963858 |
| 10 | mitotic G2/M transition checkpoint (GO:0044818) | 4.26078904 |
| 11 | peptide hormone processing (GO:0016486) | 4.18770956 |
| 12 | establishment of viral latency (GO:0019043) | 4.14470956 |
| 13 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 4.08067342 |
| 14 | pre-miRNA processing (GO:0031054) | 4.07943326 |
| 15 | detection of calcium ion (GO:0005513) | 4.07450676 |
| 16 | insulin secretion (GO:0030073) | 4.05714633 |
| 17 | melanin biosynthetic process (GO:0042438) | 4.00216080 |
| 18 | histone exchange (GO:0043486) | 3.97920225 |
| 19 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.97176201 |
| 20 | positive regulation of mast cell activation (GO:0033005) | 3.97073144 |
| 21 | negative regulation of norepinephrine secretion (GO:0010700) | 3.93588747 |
| 22 | endocrine pancreas development (GO:0031018) | 3.90692992 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.85577745 |
| 24 | negative regulation of catecholamine secretion (GO:0033604) | 3.83316285 |
| 25 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.81135766 |
| 26 | positive regulation of mast cell degranulation (GO:0043306) | 3.81135766 |
| 27 | regulation of penile erection (GO:0060405) | 3.80300031 |
| 28 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.79105647 |
| 29 | regulation of gene silencing by miRNA (GO:0060964) | 3.78894233 |
| 30 | regulation of gene silencing by RNA (GO:0060966) | 3.78894233 |
| 31 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.78894233 |
| 32 | DNA replication-independent nucleosome organization (GO:0034724) | 3.75921336 |
| 33 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.75921336 |
| 34 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.74440795 |
| 35 | synaptic vesicle exocytosis (GO:0016079) | 3.70686568 |
| 36 | synaptic vesicle maturation (GO:0016188) | 3.67182424 |
| 37 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.64774747 |
| 38 | phagocytosis, engulfment (GO:0006911) | 3.64383440 |
| 39 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.58257798 |
| 40 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.53545144 |
| 41 | DNA double-strand break processing (GO:0000729) | 3.52844933 |
| 42 | melanin metabolic process (GO:0006582) | 3.46308351 |
| 43 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.45279741 |
| 44 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.45279741 |
| 45 | regulation of insulin secretion (GO:0050796) | 3.43869311 |
| 46 | secondary metabolite biosynthetic process (GO:0044550) | 3.43478735 |
| 47 | positive regulation of insulin secretion (GO:0032024) | 3.42609488 |
| 48 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.40030478 |
| 49 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.40030478 |
| 50 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.40030478 |
| 51 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.40030478 |
| 52 | negative regulation of sister chromatid segregation (GO:0033046) | 3.40030478 |
| 53 | non-recombinational repair (GO:0000726) | 3.35898377 |
| 54 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.35898377 |
| 55 | single strand break repair (GO:0000012) | 3.35345490 |
| 56 | DNA ligation (GO:0006266) | 3.32819310 |
| 57 | proteasome assembly (GO:0043248) | 3.29763245 |
| 58 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.27319790 |
| 59 | regulation of glucocorticoid secretion (GO:2000849) | 3.24062256 |
| 60 | negative regulation of chromosome segregation (GO:0051985) | 3.22621981 |
| 61 | neuronal action potential propagation (GO:0019227) | 3.21485793 |
| 62 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.20603113 |
| 63 | ER overload response (GO:0006983) | 3.19867387 |
| 64 | COPII vesicle coating (GO:0048208) | 3.18674177 |
| 65 | vesicle coating (GO:0006901) | 3.18673449 |
| 66 | protein retention in ER lumen (GO:0006621) | 3.14206430 |
| 67 | regulation of norepinephrine secretion (GO:0014061) | 3.13918196 |
| 68 | cellular response to glucagon stimulus (GO:0071377) | 3.12393203 |
| 69 | regulation of cell fate specification (GO:0042659) | 3.12324181 |
| 70 | protein localization to Golgi apparatus (GO:0034067) | 3.11772778 |
| 71 | regulation of peptide hormone secretion (GO:0090276) | 3.11210429 |
| 72 | spindle checkpoint (GO:0031577) | 3.10188801 |
| 73 | regulation of synaptic vesicle transport (GO:1902803) | 3.09879218 |
| 74 | mitotic spindle assembly checkpoint (GO:0007094) | 3.09785767 |
| 75 | sequestering of metal ion (GO:0051238) | 3.09757525 |
| 76 | mitotic spindle checkpoint (GO:0071174) | 3.09667283 |
| 77 | peptide hormone secretion (GO:0030072) | 3.08620721 |
| 78 | regulation of peptide secretion (GO:0002791) | 3.08387248 |
| 79 | activation of protein kinase A activity (GO:0034199) | 3.08108650 |
| 80 | neuron cell-cell adhesion (GO:0007158) | 3.08058847 |
| 81 | nitric oxide mediated signal transduction (GO:0007263) | 3.07283088 |
| 82 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.07045678 |
| 83 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.07045678 |
| 84 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.04896831 |
| 85 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.04896831 |
| 86 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.04896831 |
| 87 | spindle assembly checkpoint (GO:0071173) | 3.03231005 |
| 88 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.02868557 |
| 89 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.02367934 |
| 90 | peptide secretion (GO:0002790) | 3.01269145 |
| 91 | locomotory exploration behavior (GO:0035641) | 3.00664431 |
| 92 | sequestering of actin monomers (GO:0042989) | 2.98341755 |
| 93 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.97717188 |
| 94 | regulation of sister chromatid segregation (GO:0033045) | 2.96282654 |
| 95 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.96282654 |
| 96 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.96282654 |
| 97 | exocrine pancreas development (GO:0031017) | 2.95909356 |
| 98 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.94554505 |
| 99 | signal peptide processing (GO:0006465) | 2.94142138 |
| 100 | protein targeting to Golgi (GO:0000042) | 2.92585940 |
| 101 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.92364648 |
| 102 | regulation of helicase activity (GO:0051095) | 2.91657289 |
| 103 | cerebellar Purkinje cell layer development (GO:0021680) | 2.91240874 |
| 104 | neurotransmitter secretion (GO:0007269) | 2.91102528 |
| 105 | histone mRNA metabolic process (GO:0008334) | 2.88814889 |
| 106 | melanosome transport (GO:0032402) | 2.87243180 |
| 107 | type B pancreatic cell development (GO:0003323) | 2.86513005 |
| 108 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.85665400 |
| 109 | membrane invagination (GO:0010324) | 2.85029352 |
| 110 | regulation of mast cell activation (GO:0033003) | 2.85019375 |
| 111 | protein localization to kinetochore (GO:0034501) | 2.84087880 |
| 112 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.83213260 |
| 113 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.83213260 |
| 114 | vesicle transport along microtubule (GO:0047496) | 2.81674847 |
| 115 | respiratory burst (GO:0045730) | 2.81125164 |
| 116 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.80301397 |
| 117 | regulation of beta-amyloid formation (GO:1902003) | 2.79024398 |
| 118 | positive regulation of peptide hormone secretion (GO:0090277) | 2.79007053 |
| 119 | establishment of melanosome localization (GO:0032401) | 2.78726810 |
| 120 | regulation of hormone secretion (GO:0046883) | 2.78086784 |
| 121 | ATP-dependent chromatin remodeling (GO:0043044) | 2.77690155 |
| 122 | negative regulation of amine transport (GO:0051953) | 2.77608114 |
| 123 | positive regulation of peptide secretion (GO:0002793) | 2.77314302 |
| 124 | Rap protein signal transduction (GO:0032486) | 2.77155747 |
| 125 | regulation of chromatin silencing (GO:0031935) | 2.75867427 |
| 126 | vocalization behavior (GO:0071625) | 2.75292847 |
| 127 | glandular epithelial cell differentiation (GO:0002067) | 2.74933313 |
| 128 | regulation of DNA endoreduplication (GO:0032875) | 2.73738843 |
| 129 | transferrin transport (GO:0033572) | 2.73496622 |
| 130 | presynaptic membrane assembly (GO:0097105) | 2.73342484 |
| 131 | regulation of histone H3-K9 methylation (GO:0051570) | 2.72822990 |
| 132 | regulation of chromosome segregation (GO:0051983) | 2.72745963 |
| 133 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.72711577 |
| 134 | cullin deneddylation (GO:0010388) | 2.72620232 |
| 135 | positive regulation of vesicle fusion (GO:0031340) | 2.72439066 |
| 136 | pigment granule transport (GO:0051904) | 2.71184938 |
| 137 | positive regulation of amino acid transport (GO:0051957) | 2.70898429 |
| 138 | IMP metabolic process (GO:0046040) | 2.70245101 |
| 139 | toxin metabolic process (GO:0009404) | 2.69735791 |
| 140 | signal release (GO:0023061) | 2.69556459 |
| 141 | mitotic metaphase plate congression (GO:0007080) | 2.69381304 |
| 142 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.68852386 |
| 143 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.68852386 |
| 144 | isotype switching (GO:0045190) | 2.68852386 |
| 145 | synapsis (GO:0007129) | 2.68639038 |
| 146 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.68221293 |
| 147 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.67957988 |
| 148 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.67957988 |
| 149 | regulation of mesoderm development (GO:2000380) | 2.67496014 |
| 150 | mating behavior (GO:0007617) | 2.66935531 |
| 151 | regulation of vesicle fusion (GO:0031338) | 2.65975027 |
| 152 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.65653892 |
| 153 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.65471034 |
| 154 | negative regulation of gene silencing (GO:0060969) | 2.65159360 |
| 155 | response to X-ray (GO:0010165) | 2.64509624 |
| 156 | organelle transport along microtubule (GO:0072384) | 2.64413702 |
| 157 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.64333310 |
| 158 | establishment of pigment granule localization (GO:0051905) | 2.63785596 |
| 159 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.63474692 |
| 160 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.62953842 |
| 161 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.62863271 |
| 162 | DNA damage response, detection of DNA damage (GO:0042769) | 2.62726045 |
| 163 | regulation of gene silencing (GO:0060968) | 2.62302013 |
| 164 | dorsal/ventral axis specification (GO:0009950) | 2.59411575 |
| 165 | glandular epithelial cell development (GO:0002068) | 2.58481550 |
| 166 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.58465657 |
| 167 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.57526371 |
| 168 | ferric iron transport (GO:0015682) | 2.57233123 |
| 169 | trivalent inorganic cation transport (GO:0072512) | 2.57233123 |
| 170 | regulation of cofactor metabolic process (GO:0051193) | 2.56190597 |
| 171 | regulation of coenzyme metabolic process (GO:0051196) | 2.56190597 |
| 172 | positive regulation of exocytosis (GO:0045921) | 2.55782084 |
| 173 | protein localization to synapse (GO:0035418) | 2.55777687 |
| 174 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.55315211 |
| 175 | hormone secretion (GO:0046879) | 2.54665818 |
| 176 | establishment of chromosome localization (GO:0051303) | 2.54489901 |
| 177 | regulation of peptide transport (GO:0090087) | 2.53583947 |
| 178 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.52561948 |
| 179 | protein K11-linked ubiquitination (GO:0070979) | 2.52520402 |
| 180 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.52294869 |
| 181 | protein complex localization (GO:0031503) | 2.52078717 |
| 182 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.51892430 |
| 183 | B cell mediated immunity (GO:0019724) | 2.51871432 |
| 184 | establishment of protein localization to Golgi (GO:0072600) | 2.51687820 |
| 185 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.51016375 |
| 186 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.50759296 |
| 187 | developmental pigmentation (GO:0048066) | 2.50483864 |
| 188 | suckling behavior (GO:0001967) | 2.50256322 |
| 189 | regulation of exocytosis (GO:0017157) | 2.49882601 |
| 190 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.49717802 |
| 191 | myeloid leukocyte mediated immunity (GO:0002444) | 2.49014828 |
| 192 | anterior/posterior axis specification, embryo (GO:0008595) | 2.48184082 |
| 193 | melanosome localization (GO:0032400) | 2.46840824 |
| 194 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.46539662 |
| 195 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.46311056 |
| 196 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.45294971 |
| 197 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.44866602 |
| 198 | eating behavior (GO:0042755) | 2.44605944 |
| 199 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.44358090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.91646533 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.25433556 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.87446979 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.69467775 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.67914340 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.58087953 |
| 7 | EWS_26573619_Chip-Seq_HEK293_Human | 2.49968140 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.46628793 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.41593097 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.39484041 |
| 11 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.34997578 |
| 12 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 2.29631497 |
| 13 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.26407462 |
| 14 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.26245289 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.21773251 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.20748420 |
| 17 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.18607737 |
| 18 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.17384693 |
| 19 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.13732036 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08208716 |
| 21 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.07008890 |
| 22 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.06659063 |
| 23 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.05500159 |
| 24 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.04714127 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.02090047 |
| 26 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01738705 |
| 27 | * NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.00747765 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.00542426 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.96303315 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.95519305 |
| 31 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.90855292 |
| 32 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.85546072 |
| 33 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.85097097 |
| 34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.84887215 |
| 35 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.84598187 |
| 36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81089319 |
| 37 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80053367 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.79760610 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78896810 |
| 40 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78896810 |
| 41 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.77776249 |
| 42 | VDR_22108803_ChIP-Seq_LS180_Human | 1.77418954 |
| 43 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.76813349 |
| 44 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.76080126 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.72983331 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.70950997 |
| 47 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70202637 |
| 48 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.70029015 |
| 49 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.70029015 |
| 50 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.70029015 |
| 51 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.69602103 |
| 52 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.68718421 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67419930 |
| 54 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.66897008 |
| 55 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64475159 |
| 56 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.62328147 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.60457914 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59760111 |
| 59 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.58614620 |
| 60 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.57996613 |
| 61 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56821196 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.55585380 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.54152468 |
| 64 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.51345169 |
| 65 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.51225402 |
| 66 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.50892796 |
| 67 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.47020923 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46615077 |
| 69 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.45582078 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45475798 |
| 71 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43464886 |
| 72 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.42170725 |
| 73 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.41284101 |
| 74 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.39298006 |
| 75 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.38419219 |
| 76 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.38125187 |
| 77 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.37784724 |
| 78 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.35624053 |
| 79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.35515556 |
| 80 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.35065184 |
| 81 | * SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.34397664 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33942301 |
| 83 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.32996977 |
| 84 | * CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29428578 |
| 85 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.29201202 |
| 86 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28707294 |
| 87 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.27998758 |
| 88 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.27438573 |
| 89 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25538878 |
| 90 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.24784942 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24218438 |
| 92 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.23201556 |
| 93 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.21031019 |
| 94 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.20542371 |
| 95 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.20410403 |
| 96 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20331223 |
| 97 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.20331223 |
| 98 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17763848 |
| 99 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.17210511 |
| 100 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.17067693 |
| 101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.16078711 |
| 102 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15728926 |
| 103 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.14906377 |
| 104 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.14863132 |
| 105 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14408336 |
| 106 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.14074416 |
| 107 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14046639 |
| 108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13539439 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13519298 |
| 110 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.11264755 |
| 111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10978756 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.10910328 |
| 113 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10658512 |
| 114 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.09954757 |
| 115 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09839908 |
| 116 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.09763986 |
| 117 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09457156 |
| 118 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.08659208 |
| 119 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.08424092 |
| 120 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08362114 |
| 121 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.07985552 |
| 122 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.07606956 |
| 123 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07539061 |
| 124 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06863284 |
| 125 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.06577572 |
| 126 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06538455 |
| 127 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.06362314 |
| 128 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.06135051 |
| 129 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05836260 |
| 130 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.05277994 |
| 131 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.05053520 |
| 132 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04944514 |
| 133 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04435107 |
| 134 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04249225 |
| 135 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.03924438 |
| 136 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03478082 |
| 137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02942043 |
| 138 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.02877302 |
| 139 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.02616694 |
| 140 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.02431456 |
| 141 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01284529 |
| 142 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.01150942 |
| 143 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00983286 |
| 144 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00681862 |
| 145 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.00240407 |
| 146 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00239766 |
| 147 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00189592 |
| 148 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98108806 |
| 149 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97762873 |
| 150 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95886813 |
| 151 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95417209 |
| 152 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94578176 |
| 153 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92035354 |
| 154 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91413765 |
| 155 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91382866 |
| 156 | AR_19668381_ChIP-Seq_PC3_Human | 0.90839582 |
| 157 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.90144357 |
| 158 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90007186 |
| 159 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89035295 |
| 160 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88874149 |
| 161 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.88069173 |
| 162 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86841770 |
| 163 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86817971 |
| 164 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.85389045 |
| 165 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.85053556 |
| 166 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.84895787 |
| 167 | JUN_21703547_ChIP-Seq_K562_Human | 0.84550912 |
| 168 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.84270649 |
| 169 | FUS_26573619_Chip-Seq_HEK293_Human | 0.83859445 |
| 170 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83336580 |
| 171 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.82438527 |
| 172 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.81959109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.68549432 |
| 2 | MP0010386_abnormal_urinary_bladder | 3.71416110 |
| 3 | MP0000013_abnormal_adipose_tissue | 3.64936192 |
| 4 | MP0005171_absent_coat_pigmentation | 3.57369442 |
| 5 | MP0006054_spinal_hemorrhage | 3.54444027 |
| 6 | MP0000372_irregular_coat_pigmentation | 3.45018485 |
| 7 | MP0002909_abnormal_adrenal_gland | 3.44405780 |
| 8 | MP0003283_abnormal_digestive_organ | 3.37994390 |
| 9 | MP0003183_abnormal_peptide_metabolism | 3.37579418 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 3.06683970 |
| 11 | MP0002837_dystrophic_cardiac_calcinosis | 2.94671086 |
| 12 | MP0003890_abnormal_embryonic-extraembry | 2.93296532 |
| 13 | MP0005075_abnormal_melanosome_morpholog | 2.91641841 |
| 14 | MP0002102_abnormal_ear_morphology | 2.82358754 |
| 15 | MP0003122_maternal_imprinting | 2.74837068 |
| 16 | MP0002877_abnormal_melanocyte_morpholog | 2.71022702 |
| 17 | MP0005379_endocrine/exocrine_gland_phen | 2.70128622 |
| 18 | MP0002693_abnormal_pancreas_physiology | 2.64427741 |
| 19 | MP0006276_abnormal_autonomic_nervous | 2.60098766 |
| 20 | MP0004270_analgesia | 2.59213050 |
| 21 | MP0002254_reproductive_system_inflammat | 2.44049117 |
| 22 | MP0008877_abnormal_DNA_methylation | 2.38495327 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 2.37867333 |
| 24 | MP0004859_abnormal_synaptic_plasticity | 2.33168995 |
| 25 | MP0004043_abnormal_pH_regulation | 2.28164801 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 2.25171751 |
| 27 | MP0003880_abnormal_central_pattern | 2.22985500 |
| 28 | MP0001944_abnormal_pancreas_morphology | 2.21408978 |
| 29 | MP0002735_abnormal_chemical_nociception | 2.20076068 |
| 30 | MP0001986_abnormal_taste_sensitivity | 2.18350762 |
| 31 | MP0002733_abnormal_thermal_nociception | 2.12170584 |
| 32 | MP0002638_abnormal_pupillary_reflex | 2.11451301 |
| 33 | MP0002090_abnormal_vision | 2.09728641 |
| 34 | MP0002734_abnormal_mechanical_nocicepti | 2.09493905 |
| 35 | MP0005646_abnormal_pituitary_gland | 2.08634475 |
| 36 | MP0008057_abnormal_DNA_replication | 2.04093877 |
| 37 | MP0003567_abnormal_fetal_cardiomyocyte | 2.01981800 |
| 38 | MP0001293_anophthalmia | 1.96666868 |
| 39 | MP0001324_abnormal_eye_pigmentation | 1.93711852 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.93153459 |
| 41 | MP0005248_abnormal_Harderian_gland | 1.90679668 |
| 42 | MP0003195_calcinosis | 1.86473895 |
| 43 | MP0001970_abnormal_pain_threshold | 1.86379523 |
| 44 | MP0005174_abnormal_tail_pigmentation | 1.84925951 |
| 45 | MP0010094_abnormal_chromosome_stability | 1.84289656 |
| 46 | MP0002064_seizures | 1.84151712 |
| 47 | MP0009745_abnormal_behavioral_response | 1.82022890 |
| 48 | MP0008058_abnormal_DNA_repair | 1.80927338 |
| 49 | MP0004957_abnormal_blastocyst_morpholog | 1.80277401 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.77724093 |
| 51 | MP0002063_abnormal_learning/memory/cond | 1.77682691 |
| 52 | MP0003221_abnormal_cardiomyocyte_apopto | 1.77259517 |
| 53 | MP0005394_taste/olfaction_phenotype | 1.75007284 |
| 54 | MP0005499_abnormal_olfactory_system | 1.75007284 |
| 55 | MP0000015_abnormal_ear_pigmentation | 1.72583404 |
| 56 | MP0002163_abnormal_gland_morphology | 1.71187514 |
| 57 | MP0008932_abnormal_embryonic_tissue | 1.70005310 |
| 58 | MP0002272_abnormal_nervous_system | 1.65504528 |
| 59 | MP0005423_abnormal_somatic_nervous | 1.64634539 |
| 60 | MP0009046_muscle_twitch | 1.63478524 |
| 61 | MP0002822_catalepsy | 1.63288443 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.53655211 |
| 63 | MP0003646_muscle_fatigue | 1.48772802 |
| 64 | MP0002078_abnormal_glucose_homeostasis | 1.47768185 |
| 65 | MP0001501_abnormal_sleep_pattern | 1.47032294 |
| 66 | MP0001188_hyperpigmentation | 1.46435416 |
| 67 | MP0002095_abnormal_skin_pigmentation | 1.46378481 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.44754010 |
| 69 | MP0003724_increased_susceptibility_to | 1.43085816 |
| 70 | MP0002184_abnormal_innervation | 1.41749614 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.41526798 |
| 72 | MP0004084_abnormal_cardiac_muscle | 1.41401694 |
| 73 | MP0004858_abnormal_nervous_system | 1.35335869 |
| 74 | MP0005671_abnormal_response_to | 1.34685393 |
| 75 | MP0002067_abnormal_sensory_capabilities | 1.34267450 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.33866045 |
| 77 | MP0008961_abnormal_basal_metabolism | 1.33010662 |
| 78 | MP0009672_abnormal_birth_weight | 1.31982939 |
| 79 | MP0006292_abnormal_olfactory_placode | 1.31800355 |
| 80 | MP0002876_abnormal_thyroid_physiology | 1.31013916 |
| 81 | MP0004133_heterotaxia | 1.30889960 |
| 82 | MP0008260_abnormal_autophagy | 1.30788302 |
| 83 | MP0000371_diluted_coat_color | 1.30086908 |
| 84 | MP0001502_abnormal_circadian_rhythm | 1.29926768 |
| 85 | MP0000678_abnormal_parathyroid_gland | 1.28545897 |
| 86 | MP0001835_abnormal_antigen_presentation | 1.27093461 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 1.23019155 |
| 88 | MP0001485_abnormal_pinna_reflex | 1.22840275 |
| 89 | MP0005058_abnormal_lysosome_morphology | 1.22653939 |
| 90 | MP0000955_abnormal_spinal_cord | 1.22628746 |
| 91 | MP0003878_abnormal_ear_physiology | 1.21233364 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 1.21233364 |
| 93 | MP0004811_abnormal_neuron_physiology | 1.20785463 |
| 94 | MP0000538_abnormal_urinary_bladder | 1.20186096 |
| 95 | MP0001440_abnormal_grooming_behavior | 1.17804663 |
| 96 | MP0003111_abnormal_nucleus_morphology | 1.17590258 |
| 97 | MP0005464_abnormal_platelet_physiology | 1.17304179 |
| 98 | MP0008004_abnormal_stomach_pH | 1.16382291 |
| 99 | MP0004510_myositis | 1.16238264 |
| 100 | MP0002928_abnormal_bile_duct | 1.13682706 |
| 101 | MP0005408_hypopigmentation | 1.12157312 |
| 102 | MP0003077_abnormal_cell_cycle | 1.11494835 |
| 103 | MP0001299_abnormal_eye_distance/ | 1.10900927 |
| 104 | MP0005535_abnormal_body_temperature | 1.09834516 |
| 105 | MP0001529_abnormal_vocalization | 1.09530660 |
| 106 | MP0001486_abnormal_startle_reflex | 1.08523454 |
| 107 | MP0002938_white_spotting | 1.08147919 |
| 108 | MP0004145_abnormal_muscle_electrophysio | 1.07233551 |
| 109 | MP0003787_abnormal_imprinting | 1.07037223 |
| 110 | MP0004215_abnormal_myocardial_fiber | 1.05858718 |
| 111 | MP0006082_CNS_inflammation | 1.05747477 |
| 112 | MP0005367_renal/urinary_system_phenotyp | 1.05652474 |
| 113 | MP0000516_abnormal_urinary_system | 1.05652474 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 1.05077749 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 1.04540921 |
| 116 | MP0004924_abnormal_behavior | 1.03980946 |
| 117 | MP0005386_behavior/neurological_phenoty | 1.03980946 |
| 118 | MP0008569_lethality_at_weaning | 1.03599050 |
| 119 | MP0001984_abnormal_olfaction | 1.03213550 |
| 120 | MP0004381_abnormal_hair_follicle | 1.02921133 |
| 121 | MP0002736_abnormal_nociception_after | 1.02752997 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 1.02617157 |
| 123 | MP0003329_amyloid_beta_deposits | 0.99422807 |
| 124 | MP0003941_abnormal_skin_development | 0.99370725 |
| 125 | MP0003137_abnormal_impulse_conducting | 0.98975869 |
| 126 | MP0003828_pulmonary_edema | 0.98263935 |
| 127 | MP0002751_abnormal_autonomic_nervous | 0.97527054 |
| 128 | MP0008789_abnormal_olfactory_epithelium | 0.96142402 |
| 129 | MP0003879_abnormal_hair_cell | 0.95903667 |
| 130 | MP0000465_gastrointestinal_hemorrhage | 0.95484302 |
| 131 | MP0003953_abnormal_hormone_level | 0.94902110 |
| 132 | MP0002882_abnormal_neuron_morphology | 0.94104348 |
| 133 | MP0003634_abnormal_glial_cell | 0.92488056 |
| 134 | MP0001905_abnormal_dopamine_level | 0.92329273 |
| 135 | MP0003119_abnormal_digestive_system | 0.91691025 |
| 136 | MP0002972_abnormal_cardiac_muscle | 0.90854610 |
| 137 | MP0005448_abnormal_energy_balance | 0.90471763 |
| 138 | MP0002229_neurodegeneration | 0.89661780 |
| 139 | MP0009703_decreased_birth_body | 0.88244928 |
| 140 | MP0002066_abnormal_motor_capabilities/c | 0.88230702 |
| 141 | MP0002069_abnormal_eating/drinking_beha | 0.88075058 |
| 142 | MP0004484_altered_response_of | 0.87756339 |
| 143 | MP0001915_intracranial_hemorrhage | 0.87454534 |
| 144 | MP0005167_abnormal_blood-brain_barrier | 0.86780380 |
| 145 | MP0001270_distended_abdomen | 0.85753396 |
| 146 | MP0001348_abnormal_lacrimal_gland | 0.85529961 |
| 147 | MP0002419_abnormal_innate_immunity | 0.83657622 |
| 148 | MP0003937_abnormal_limbs/digits/tail_de | 0.81331052 |
| 149 | MP0000462_abnormal_digestive_system | 0.80914886 |
| 150 | MP0003806_abnormal_nucleotide_metabolis | 0.80496766 |
| 151 | MP0004197_abnormal_fetal_growth/weight/ | 0.79886837 |
| 152 | MP0003303_peritoneal_inflammation | 0.79803088 |
| 153 | MP0002084_abnormal_developmental_patter | 0.79360337 |
| 154 | MP0002075_abnormal_coat/hair_pigmentati | 0.79227280 |
| 155 | MP0003121_genomic_imprinting | 0.78935550 |
| 156 | MP0003186_abnormal_redox_activity | 0.78900732 |
| 157 | MP0005253_abnormal_eye_physiology | 0.78820423 |
| 158 | MP0001730_embryonic_growth_arrest | 0.78777298 |
| 159 | MP0001765_abnormal_ion_homeostasis | 0.78733375 |
| 160 | MP0008007_abnormal_cellular_replicative | 0.77924354 |
| 161 | MP0003633_abnormal_nervous_system | 0.77687732 |
| 162 | MP0005310_abnormal_salivary_gland | 0.77518857 |
| 163 | MP0002896_abnormal_bone_mineralization | 0.77231194 |
| 164 | MP0009278_abnormal_bone_marrow | 0.77074654 |
| 165 | MP0004085_abnormal_heartbeat | 0.75447798 |
| 166 | MP0005197_abnormal_uvea_morphology | 0.75418130 |
| 167 | MP0001186_pigmentation_phenotype | 0.75287451 |
| 168 | MP0000639_abnormal_adrenal_gland | 0.74985112 |
| 169 | MP0000778_abnormal_nervous_system | 0.74337755 |
| 170 | MP0000681_abnormal_thyroid_gland | 0.74036173 |
| 171 | MP0003959_abnormal_lean_body | 0.72810982 |
| 172 | MP0000647_abnormal_sebaceous_gland | 0.72414026 |
| 173 | MP0003693_abnormal_embryo_hatching | 0.71852951 |
| 174 | MP0004142_abnormal_muscle_tone | 0.71706741 |
| 175 | MP0001672_abnormal_embryogenesis/_devel | 0.69493127 |
| 176 | MP0005380_embryogenesis_phenotype | 0.69493127 |
| 177 | MP0001664_abnormal_digestion | 0.69075066 |
| 178 | MP0000358_abnormal_cell_content/ | 0.69069683 |
| 179 | MP0002148_abnormal_hypersensitivity_rea | 0.68989722 |
| 180 | MP0000230_abnormal_systemic_arterial | 0.68299426 |
| 181 | MP0000343_altered_response_to | 0.68172103 |
| 182 | MP0005257_abnormal_intraocular_pressure | 0.66884271 |
| 183 | MP0004036_abnormal_muscle_relaxation | 0.66228951 |
| 184 | MP0002233_abnormal_nose_morphology | 0.66223867 |
| 185 | MP0000569_abnormal_digit_pigmentation | 0.65641834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 5.92486065 |
| 2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.18033427 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.68298960 |
| 4 | Hypothermia (HP:0002045) | 4.33438029 |
| 5 | Symptomatic seizures (HP:0011145) | 4.32535756 |
| 6 | Agitation (HP:0000713) | 4.13876140 |
| 7 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.09816655 |
| 8 | Cortical dysplasia (HP:0002539) | 4.00694200 |
| 9 | Visual hallucinations (HP:0002367) | 3.95437045 |
| 10 | Pheochromocytoma (HP:0002666) | 3.73994581 |
| 11 | Amyotrophic lateral sclerosis (HP:0007354) | 3.73649656 |
| 12 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.58990333 |
| 13 | Focal motor seizures (HP:0011153) | 3.57525520 |
| 14 | Exercise-induced muscle cramps (HP:0003710) | 3.55659764 |
| 15 | Atonic seizures (HP:0010819) | 3.47852028 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.45646596 |
| 17 | Septo-optic dysplasia (HP:0100842) | 3.40806271 |
| 18 | Colon cancer (HP:0003003) | 3.34905766 |
| 19 | Papilledema (HP:0001085) | 3.30464909 |
| 20 | Neuroendocrine neoplasm (HP:0100634) | 3.28325296 |
| 21 | Mucopolysacchariduria (HP:0008155) | 3.26644506 |
| 22 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.26644506 |
| 23 | Failure to thrive in infancy (HP:0001531) | 3.25048486 |
| 24 | Agnosia (HP:0010524) | 3.21804540 |
| 25 | Aplasia/Hypoplasia of the macula (HP:0008059) | 3.19892949 |
| 26 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.17704370 |
| 27 | Hypoplasia of the fovea (HP:0007750) | 3.17704370 |
| 28 | Menstrual irregularities (HP:0000858) | 3.16771485 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.14962319 |
| 30 | Decreased circulating renin level (HP:0003351) | 3.14426875 |
| 31 | Hyperglycemia (HP:0003074) | 3.10693175 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.10483989 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.10483989 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.10483989 |
| 35 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 3.10234285 |
| 36 | Disinhibition (HP:0000734) | 2.96088959 |
| 37 | Ketoacidosis (HP:0001993) | 2.94859508 |
| 38 | White forelock (HP:0002211) | 2.91738681 |
| 39 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.89692199 |
| 40 | Patchy hypopigmentation of hair (HP:0011365) | 2.87887048 |
| 41 | Hypercortisolism (HP:0001578) | 2.85694373 |
| 42 | Large for gestational age (HP:0001520) | 2.75223978 |
| 43 | Abnormal auditory evoked potentials (HP:0006958) | 2.70941932 |
| 44 | Limb dystonia (HP:0002451) | 2.69989585 |
| 45 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.67340697 |
| 46 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.67340697 |
| 47 | Papillary thyroid carcinoma (HP:0002895) | 2.63548467 |
| 48 | Supranuclear gaze palsy (HP:0000605) | 2.62433622 |
| 49 | Febrile seizures (HP:0002373) | 2.61429892 |
| 50 | Abnormal pancreas size (HP:0012094) | 2.60465690 |
| 51 | EEG with generalized epileptiform discharges (HP:0011198) | 2.59660208 |
| 52 | Volvulus (HP:0002580) | 2.58150322 |
| 53 | Absence seizures (HP:0002121) | 2.56966752 |
| 54 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.56747297 |
| 55 | Embryonal renal neoplasm (HP:0011794) | 2.56512170 |
| 56 | Hypsarrhythmia (HP:0002521) | 2.55673277 |
| 57 | Hyperparathyroidism (HP:0000843) | 2.54698258 |
| 58 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.53620741 |
| 59 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.53620741 |
| 60 | Hepatoblastoma (HP:0002884) | 2.53521341 |
| 61 | Late onset (HP:0003584) | 2.51747346 |
| 62 | Focal seizures (HP:0007359) | 2.51438288 |
| 63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.50954070 |
| 64 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.50954070 |
| 65 | Abnormality of glycolipid metabolism (HP:0010969) | 2.50954070 |
| 66 | Spastic diplegia (HP:0001264) | 2.49572906 |
| 67 | Inappropriate behavior (HP:0000719) | 2.48951690 |
| 68 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.48106361 |
| 69 | Epileptiform EEG discharges (HP:0011182) | 2.47390472 |
| 70 | Stenosis of the external auditory canal (HP:0000402) | 2.46450572 |
| 71 | Supernumerary spleens (HP:0009799) | 2.45880572 |
| 72 | Abnormal lung lobation (HP:0002101) | 2.44064674 |
| 73 | Generalized tonic-clonic seizures (HP:0002069) | 2.43149382 |
| 74 | Gait imbalance (HP:0002141) | 2.42917958 |
| 75 | Anxiety (HP:0000739) | 2.41387339 |
| 76 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.38948467 |
| 77 | Abnormality of the labia minora (HP:0012880) | 2.36824277 |
| 78 | Oligomenorrhea (HP:0000876) | 2.34642617 |
| 79 | Medial flaring of the eyebrow (HP:0010747) | 2.34330946 |
| 80 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.33386280 |
| 81 | Rhabdomyosarcoma (HP:0002859) | 2.32661405 |
| 82 | Depression (HP:0000716) | 2.31442646 |
| 83 | Abnormality of the septum pellucidum (HP:0007375) | 2.31367038 |
| 84 | Intestinal atresia (HP:0011100) | 2.30845653 |
| 85 | Degeneration of anterior horn cells (HP:0002398) | 2.29515715 |
| 86 | Abnormality of the anterior horn cell (HP:0006802) | 2.29515715 |
| 87 | Retinal atrophy (HP:0001105) | 2.29462788 |
| 88 | Rimmed vacuoles (HP:0003805) | 2.29381665 |
| 89 | Progressive neurologic deterioration (HP:0002344) | 2.25808079 |
| 90 | Epileptic encephalopathy (HP:0200134) | 2.25725172 |
| 91 | Hypokalemia (HP:0002900) | 2.24909336 |
| 92 | Abnormality of chromosome stability (HP:0003220) | 2.24522185 |
| 93 | Progressive inability to walk (HP:0002505) | 2.24057298 |
| 94 | Postural tremor (HP:0002174) | 2.22267598 |
| 95 | Absent septum pellucidum (HP:0001331) | 2.21185187 |
| 96 | Congenital primary aphakia (HP:0007707) | 2.20672100 |
| 97 | Medulloblastoma (HP:0002885) | 2.20608769 |
| 98 | Gastrointestinal carcinoma (HP:0002672) | 2.20588888 |
| 99 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.20588888 |
| 100 | Dialeptic seizures (HP:0011146) | 2.20313072 |
| 101 | Testicular neoplasm (HP:0010788) | 2.19362005 |
| 102 | Hyperglycinemia (HP:0002154) | 2.17681297 |
| 103 | Thoracolumbar scoliosis (HP:0002944) | 2.17102842 |
| 104 | Truncal ataxia (HP:0002078) | 2.16916499 |
| 105 | Thyroid carcinoma (HP:0002890) | 2.16785746 |
| 106 | Dyschromatopsia (HP:0007641) | 2.16301958 |
| 107 | Uterine leiomyosarcoma (HP:0002891) | 2.11825259 |
| 108 | Leiomyosarcoma (HP:0100243) | 2.11825259 |
| 109 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10890640 |
| 110 | Bladder neoplasm (HP:0009725) | 2.10807382 |
| 111 | Bladder carcinoma (HP:0002862) | 2.10807382 |
| 112 | Recurrent bacterial skin infections (HP:0005406) | 2.10100354 |
| 113 | Shoulder girdle muscle weakness (HP:0003547) | 2.09189885 |
| 114 | Insidious onset (HP:0003587) | 2.07804789 |
| 115 | Termporal pattern (HP:0011008) | 2.07804789 |
| 116 | Dysautonomia (HP:0002459) | 2.07646142 |
| 117 | Rectovaginal fistula (HP:0000143) | 2.07591554 |
| 118 | Rectal fistula (HP:0100590) | 2.07591554 |
| 119 | Pelvic girdle muscle weakness (HP:0003749) | 2.05482605 |
| 120 | Amaurosis fugax (HP:0100576) | 2.05292064 |
| 121 | Myokymia (HP:0002411) | 2.05181021 |
| 122 | Ankle clonus (HP:0011448) | 2.05081572 |
| 123 | Iris hypopigmentation (HP:0007730) | 2.03577789 |
| 124 | Restlessness (HP:0000711) | 2.02968795 |
| 125 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.00610628 |
| 126 | Abnormal platelet volume (HP:0011876) | 2.00479710 |
| 127 | Abnormality of the fovea (HP:0000493) | 1.99704313 |
| 128 | Aqueductal stenosis (HP:0002410) | 1.97348581 |
| 129 | Generalized hypopigmentation (HP:0007513) | 1.96953810 |
| 130 | Abnormal hair whorl (HP:0010721) | 1.96693157 |
| 131 | Resting tremor (HP:0002322) | 1.96575185 |
| 132 | Disproportionate short-trunk short stature (HP:0003521) | 1.96340177 |
| 133 | Increased mean platelet volume (HP:0011877) | 1.96253012 |
| 134 | Progressive cerebellar ataxia (HP:0002073) | 1.95976090 |
| 135 | Nephrogenic diabetes insipidus (HP:0009806) | 1.94516112 |
| 136 | Heterochromia iridis (HP:0001100) | 1.94379567 |
| 137 | Biliary tract neoplasm (HP:0100574) | 1.94324961 |
| 138 | Osteomalacia (HP:0002749) | 1.93705459 |
| 139 | Growth hormone excess (HP:0000845) | 1.93345776 |
| 140 | Short tibia (HP:0005736) | 1.92653091 |
| 141 | Drooling (HP:0002307) | 1.91998158 |
| 142 | Excessive salivation (HP:0003781) | 1.91998158 |
| 143 | Uterine neoplasm (HP:0010784) | 1.91359592 |
| 144 | Hematochezia (HP:0002573) | 1.89084342 |
| 145 | Optic nerve hypoplasia (HP:0000609) | 1.88859122 |
| 146 | Blue irides (HP:0000635) | 1.88538378 |
| 147 | Adrenal overactivity (HP:0002717) | 1.88406788 |
| 148 | Breast aplasia (HP:0100783) | 1.88222354 |
| 149 | Congenital glaucoma (HP:0001087) | 1.87865421 |
| 150 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.86382159 |
| 151 | Meckel diverticulum (HP:0002245) | 1.86043616 |
| 152 | Hyperkalemia (HP:0002153) | 1.85576317 |
| 153 | Macroorchidism (HP:0000053) | 1.85327612 |
| 154 | Hyperphosphatemia (HP:0002905) | 1.85165683 |
| 155 | Recurrent abscess formation (HP:0002722) | 1.84830072 |
| 156 | Increased cerebral lipofuscin (HP:0011813) | 1.83777649 |
| 157 | Gonadotropin excess (HP:0000837) | 1.83371606 |
| 158 | Psychosis (HP:0000709) | 1.82560046 |
| 159 | Abolished electroretinogram (ERG) (HP:0000550) | 1.82433200 |
| 160 | Broad foot (HP:0001769) | 1.81735824 |
| 161 | Spinal canal stenosis (HP:0003416) | 1.81335094 |
| 162 | Abnormality of renin-angiotensin system (HP:0000847) | 1.81157020 |
| 163 | Neoplasm of the small intestine (HP:0100833) | 1.80942946 |
| 164 | Methylmalonic acidemia (HP:0002912) | 1.78941515 |
| 165 | Hypoventilation (HP:0002791) | 1.78814207 |
| 166 | Abnormality of potassium homeostasis (HP:0011042) | 1.78705412 |
| 167 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.78555923 |
| 168 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.77984367 |
| 169 | Neurofibrillary tangles (HP:0002185) | 1.77966636 |
| 170 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.77433272 |
| 171 | Action tremor (HP:0002345) | 1.77084858 |
| 172 | Bifid tongue (HP:0010297) | 1.76440955 |
| 173 | Cortical visual impairment (HP:0100704) | 1.74834736 |
| 174 | Petechiae (HP:0000967) | 1.74579477 |
| 175 | Erectile abnormalities (HP:0100639) | 1.74481112 |
| 176 | Genital tract atresia (HP:0001827) | 1.74423131 |
| 177 | Vaginal atresia (HP:0000148) | 1.74381054 |
| 178 | Abnormality of the ileum (HP:0001549) | 1.74122196 |
| 179 | Tetraparesis (HP:0002273) | 1.73384018 |
| 180 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73034677 |
| 181 | Neoplasm of the colon (HP:0100273) | 1.72103653 |
| 182 | Abnormal eating behavior (HP:0100738) | 1.71170392 |
| 183 | Short middle phalanx of the 5th finger (HP:0004220) | 1.70083123 |
| 184 | Split foot (HP:0001839) | 1.69868739 |
| 185 | Delayed gross motor development (HP:0002194) | 1.69764571 |
| 186 | Hyperthyroidism (HP:0000836) | 1.68446927 |
| 187 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.68184092 |
| 188 | Vacuolated lymphocytes (HP:0001922) | 1.68055809 |
| 189 | Exertional dyspnea (HP:0002875) | 1.66677016 |
| 190 | Abnormality of the lower motor neuron (HP:0002366) | 1.66665933 |
| 191 | Ulnar claw (HP:0001178) | 1.66182887 |
| 192 | T lymphocytopenia (HP:0005403) | 1.65727222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 4.77039559 |
| 2 | TRIM28 | 3.73008810 |
| 3 | MAPK15 | 3.66433622 |
| 4 | NTRK3 | 3.53751542 |
| 5 | PASK | 3.29229624 |
| 6 | CDK19 | 3.25695969 |
| 7 | MKNK1 | 2.68415002 |
| 8 | MKNK2 | 2.67476985 |
| 9 | NTRK1 | 2.63230637 |
| 10 | WNK3 | 2.63196478 |
| 11 | CAMKK2 | 2.48040533 |
| 12 | HIPK2 | 2.46503780 |
| 13 | MAP3K9 | 2.38292051 |
| 14 | SCYL2 | 2.37221062 |
| 15 | MAP3K2 | 2.27317091 |
| 16 | ACVR1B | 2.11414103 |
| 17 | SRPK1 | 2.10242700 |
| 18 | UHMK1 | 2.09652778 |
| 19 | MAP3K12 | 1.97986919 |
| 20 | MARK1 | 1.95843738 |
| 21 | MINK1 | 1.95029299 |
| 22 | MAP2K7 | 1.90046956 |
| 23 | CASK | 1.82997743 |
| 24 | WNK4 | 1.81344488 |
| 25 | MAP3K4 | 1.80296415 |
| 26 | WEE1 | 1.66864109 |
| 27 | GRK5 | 1.63904906 |
| 28 | TAOK3 | 1.63091184 |
| 29 | DYRK3 | 1.62255390 |
| 30 | FGR | 1.61319066 |
| 31 | PLK4 | 1.60112399 |
| 32 | EIF2AK3 | 1.55666085 |
| 33 | PLK3 | 1.53372168 |
| 34 | PRKD3 | 1.52292382 |
| 35 | MAP3K1 | 1.51948250 |
| 36 | CDC7 | 1.51309731 |
| 37 | IRAK1 | 1.35954985 |
| 38 | NTRK2 | 1.34069299 |
| 39 | KSR2 | 1.33605040 |
| 40 | MST4 | 1.32899419 |
| 41 | ARAF | 1.32391660 |
| 42 | EPHA3 | 1.30210564 |
| 43 | PAK3 | 1.29192172 |
| 44 | RPS6KA4 | 1.29026083 |
| 45 | CSNK1G1 | 1.28469861 |
| 46 | GRK7 | 1.22232692 |
| 47 | STK38L | 1.21842932 |
| 48 | TEC | 1.19419437 |
| 49 | FER | 1.16570132 |
| 50 | FGFR1 | 1.15583429 |
| 51 | STK24 | 1.13593192 |
| 52 | FRK | 1.13396707 |
| 53 | IRAK2 | 1.09021832 |
| 54 | BLK | 1.08109354 |
| 55 | OBSCN | 1.08053085 |
| 56 | PNCK | 1.06836815 |
| 57 | CDK5 | 1.06440447 |
| 58 | PRKCE | 1.06037219 |
| 59 | KDR | 1.05424967 |
| 60 | STK3 | 1.04329100 |
| 61 | CSNK1A1L | 1.02171229 |
| 62 | PRKCH | 1.01952602 |
| 63 | RET | 1.01327027 |
| 64 | EGFR | 1.01215899 |
| 65 | MAP2K4 | 1.00799907 |
| 66 | ERBB3 | 1.00147514 |
| 67 | BRD4 | 0.99515702 |
| 68 | NEK1 | 0.98674510 |
| 69 | LIMK1 | 0.97441925 |
| 70 | STK10 | 0.95728649 |
| 71 | WNK1 | 0.94559545 |
| 72 | MARK3 | 0.94383479 |
| 73 | CAMKK1 | 0.93698517 |
| 74 | BMPR1B | 0.92955954 |
| 75 | CDK6 | 0.92276178 |
| 76 | MATK | 0.92204103 |
| 77 | MAPK13 | 0.91356400 |
| 78 | ADRBK2 | 0.86365422 |
| 79 | PDGFRA | 0.85351539 |
| 80 | OXSR1 | 0.84901604 |
| 81 | CDC42BPA | 0.84519477 |
| 82 | BUB1 | 0.80430488 |
| 83 | FES | 0.79782668 |
| 84 | BCR | 0.79580339 |
| 85 | CSF1R | 0.79181438 |
| 86 | TAF1 | 0.79142899 |
| 87 | PHKG2 | 0.78913205 |
| 88 | PHKG1 | 0.78913205 |
| 89 | TSSK6 | 0.78623348 |
| 90 | EIF2AK1 | 0.77450972 |
| 91 | TTK | 0.77442128 |
| 92 | PAK6 | 0.76908421 |
| 93 | NUAK1 | 0.76763215 |
| 94 | BMX | 0.76455039 |
| 95 | CAMK2D | 0.76413346 |
| 96 | PTK2 | 0.74730712 |
| 97 | PRKCG | 0.74305265 |
| 98 | ADRBK1 | 0.74269245 |
| 99 | PLK1 | 0.74024190 |
| 100 | EIF2AK2 | 0.72607891 |
| 101 | IRAK4 | 0.72406625 |
| 102 | CDK18 | 0.71641884 |
| 103 | SIK3 | 0.70928533 |
| 104 | RPS6KA2 | 0.66236912 |
| 105 | TIE1 | 0.63650026 |
| 106 | PBK | 0.63556871 |
| 107 | PIK3CG | 0.63055514 |
| 108 | CAMK2A | 0.61972744 |
| 109 | CSNK1G2 | 0.59842754 |
| 110 | BMPR2 | 0.58130989 |
| 111 | NEK2 | 0.57517240 |
| 112 | PLK2 | 0.57370812 |
| 113 | MUSK | 0.57271972 |
| 114 | SGK494 | 0.57133209 |
| 115 | SGK223 | 0.57133209 |
| 116 | LYN | 0.56969402 |
| 117 | CDK11A | 0.56664698 |
| 118 | MAP2K1 | 0.55748394 |
| 119 | CSK | 0.55704415 |
| 120 | CDK15 | 0.55214265 |
| 121 | DYRK1A | 0.53789107 |
| 122 | RIPK4 | 0.52263182 |
| 123 | CAMK2B | 0.52023817 |
| 124 | BRAF | 0.51928195 |
| 125 | MAP3K5 | 0.51838046 |
| 126 | SIK2 | 0.49433759 |
| 127 | DYRK1B | 0.49301978 |
| 128 | CAMK1G | 0.49206980 |
| 129 | ERBB4 | 0.48723118 |
| 130 | MAP3K10 | 0.48249042 |
| 131 | CDK14 | 0.47949008 |
| 132 | SGK2 | 0.47565753 |
| 133 | PAK4 | 0.46486680 |
| 134 | TESK1 | 0.46388087 |
| 135 | PDK2 | 0.45826053 |
| 136 | FLT3 | 0.44592855 |
| 137 | ITK | 0.44526779 |
| 138 | AKT3 | 0.44235739 |
| 139 | ALK | 0.42651095 |
| 140 | HCK | 0.42560995 |
| 141 | PINK1 | 0.42358353 |
| 142 | ATM | 0.41822245 |
| 143 | MAPK10 | 0.41564631 |
| 144 | CDK3 | 0.40737797 |
| 145 | PRKACA | 0.40626625 |
| 146 | TGFBR2 | 0.40373915 |
| 147 | SYK | 0.40097521 |
| 148 | MOS | 0.39722519 |
| 149 | ATR | 0.39669518 |
| 150 | IGF1R | 0.38889541 |
| 151 | TNK2 | 0.38793022 |
| 152 | ZAK | 0.37817986 |
| 153 | PRKD2 | 0.37211990 |
| 154 | NLK | 0.36467404 |
| 155 | PRPF4B | 0.35603100 |
| 156 | PRKACG | 0.34344860 |
| 157 | CSNK1G3 | 0.34077231 |
| 158 | ABL1 | 0.32264361 |
| 159 | ERBB2 | 0.31168033 |
| 160 | RPS6KA3 | 0.30599056 |
| 161 | KSR1 | 0.29838052 |
| 162 | PRKG1 | 0.29190235 |
| 163 | CSNK1A1 | 0.28365007 |
| 164 | ERN1 | 0.28292872 |
| 165 | SGK1 | 0.27892303 |
| 166 | DYRK2 | 0.26431043 |
| 167 | TNIK | 0.26233491 |
| 168 | YES1 | 0.25995633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.93490536 |
| 2 | Asthma_Homo sapiens_hsa05310 | 3.70451910 |
| 3 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.50335490 |
| 4 | Protein export_Homo sapiens_hsa03060 | 3.30800886 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 2.88895416 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 2.80296323 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.62124037 |
| 8 | Mismatch repair_Homo sapiens_hsa03430 | 2.53598291 |
| 9 | Viral myocarditis_Homo sapiens_hsa05416 | 2.42238948 |
| 10 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.41674399 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.37998650 |
| 12 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.35049149 |
| 13 | Allograft rejection_Homo sapiens_hsa05330 | 2.32075330 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.17971434 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.13398534 |
| 16 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.06659941 |
| 17 | Cocaine addiction_Homo sapiens_hsa05030 | 1.93934651 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.93748966 |
| 19 | Taste transduction_Homo sapiens_hsa04742 | 1.93361073 |
| 20 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.87841889 |
| 21 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.87469707 |
| 22 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.85490863 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.78528295 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.75203610 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.73423867 |
| 26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.72918124 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.68773156 |
| 28 | RNA transport_Homo sapiens_hsa03013 | 1.65483654 |
| 29 | Circadian entrainment_Homo sapiens_hsa04713 | 1.64804099 |
| 30 | Cell cycle_Homo sapiens_hsa04110 | 1.63812863 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.61262073 |
| 32 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59914712 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.59805028 |
| 34 | Morphine addiction_Homo sapiens_hsa05032 | 1.58868514 |
| 35 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.57325272 |
| 36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.57222644 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.56079942 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.55892306 |
| 39 | Homologous recombination_Homo sapiens_hsa03440 | 1.54400357 |
| 40 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.52000043 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.50722367 |
| 42 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.50168758 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48737672 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 1.46215279 |
| 45 | Spliceosome_Homo sapiens_hsa03040 | 1.41033736 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.39952960 |
| 47 | RNA degradation_Homo sapiens_hsa03018 | 1.39843190 |
| 48 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38572196 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.31482846 |
| 50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.27712049 |
| 51 | * Lysosome_Homo sapiens_hsa04142 | 1.26961041 |
| 52 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.26264731 |
| 53 | Shigellosis_Homo sapiens_hsa05131 | 1.24683984 |
| 54 | Olfactory transduction_Homo sapiens_hsa04740 | 1.24225359 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.22966393 |
| 56 | Tuberculosis_Homo sapiens_hsa05152 | 1.22580298 |
| 57 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.22387341 |
| 58 | Base excision repair_Homo sapiens_hsa03410 | 1.17293136 |
| 59 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.17128254 |
| 60 | Long-term depression_Homo sapiens_hsa04730 | 1.17121068 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16161381 |
| 62 | Parkinsons disease_Homo sapiens_hsa05012 | 1.13060546 |
| 63 | Renin secretion_Homo sapiens_hsa04924 | 1.12539463 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11776794 |
| 65 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11664562 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11644809 |
| 67 | Adherens junction_Homo sapiens_hsa04520 | 1.09405770 |
| 68 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.09240417 |
| 69 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.09110417 |
| 70 | Salmonella infection_Homo sapiens_hsa05132 | 1.07270807 |
| 71 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.07068233 |
| 72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04949983 |
| 73 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02630818 |
| 74 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99515831 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.97954381 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.96315465 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96037334 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.95975028 |
| 79 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.94921975 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.94906877 |
| 81 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.94422637 |
| 82 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93449261 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92718623 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.92660926 |
| 85 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92461631 |
| 86 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.92339307 |
| 87 | Salivary secretion_Homo sapiens_hsa04970 | 0.90297633 |
| 88 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89413108 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.86851412 |
| 90 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85944649 |
| 91 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84255527 |
| 92 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83797233 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.83589121 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.82973441 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82438236 |
| 96 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.81526639 |
| 97 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81454095 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.79535908 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.78148121 |
| 100 | Other glycan degradation_Homo sapiens_hsa00511 | 0.77432857 |
| 101 | Gap junction_Homo sapiens_hsa04540 | 0.76322708 |
| 102 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76269340 |
| 103 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.74267216 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73463195 |
| 105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.73392873 |
| 106 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.71897704 |
| 107 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71620602 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71041219 |
| 109 | Alcoholism_Homo sapiens_hsa05034 | 0.70450248 |
| 110 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70415058 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70377881 |
| 112 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69857720 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68659984 |
| 114 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.66228339 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.65291004 |
| 116 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64609214 |
| 117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.64523941 |
| 118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.63273305 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63158804 |
| 120 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62794737 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61915230 |
| 122 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61469319 |
| 123 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.61053032 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60392553 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58697269 |
| 126 | Melanogenesis_Homo sapiens_hsa04916 | 0.57952193 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.54640430 |
| 128 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52416295 |
| 129 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51818008 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.51808515 |
| 131 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50310032 |
| 132 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.49617941 |
| 133 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.48913137 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48639191 |
| 135 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48194024 |
| 136 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.48016719 |
| 137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47128061 |
| 138 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.46832929 |
| 139 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45441672 |
| 140 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44119380 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43668391 |
| 142 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43638639 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43403556 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.42499344 |
| 145 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42433108 |
| 146 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42165292 |
| 147 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41398507 |
| 148 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41238398 |
| 149 | RNA polymerase_Homo sapiens_hsa03020 | 0.40763351 |
| 150 | Insulin resistance_Homo sapiens_hsa04931 | 0.39556101 |
| 151 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.39192280 |
| 152 | Malaria_Homo sapiens_hsa05144 | 0.38061623 |
| 153 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37974094 |
| 154 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37108343 |
| 155 | Influenza A_Homo sapiens_hsa05164 | 0.36937409 |
| 156 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36351913 |
| 157 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35740732 |
| 158 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35721735 |
| 159 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34697876 |
| 160 | Tight junction_Homo sapiens_hsa04530 | 0.34689066 |
| 161 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.34229695 |
| 162 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.33888673 |
| 163 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33819249 |
| 164 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.33816916 |
| 165 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33497206 |
| 166 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33365676 |
| 167 | Phototransduction_Homo sapiens_hsa04744 | 0.33051207 |
| 168 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.31838863 |
| 169 | Carbon metabolism_Homo sapiens_hsa01200 | 0.31281215 |
| 170 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30512842 |
| 171 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.30450993 |
| 172 | Axon guidance_Homo sapiens_hsa04360 | 0.29711506 |

